Your browser doesn't support javascript.
loading
Acyclovir Has Low but Detectable Influence on HLA-B*57:01 Specificity without Inducing Hypersensitivity.
Metushi, Imir G; Wriston, Amanda; Banerjee, Priyanka; Gohlke, Bjoern Oliver; English, A Michelle; Lucas, Andrew; Moore, Carrie; Sidney, John; Buus, Soren; Ostrov, David A; Mallal, Simon; Phillips, Elizabeth; Shabanowitz, Jeffrey; Hunt, Donald F; Preissner, Robert; Peters, Bjoern.
Afiliación
  • Metushi IG; Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, California, United States of America.
  • Wriston A; Department of Chemistry, University of Virginia, Charlottesville, Virginia, United States of America.
  • Banerjee P; Charite-University Medicine Berlin, Institute of Physiology & Experimental Clinical Research Center, Berlin, Germany; Graduate School of Computational Systems Biology, Humboldt-Universität zu Berlin, Berlin, Germany.
  • Gohlke BO; Charite-University Medicine Berlin, Institute of Physiology & Experimental Clinical Research Center, Berlin, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany.
  • English AM; Department of Chemistry, University of Virginia, Charlottesville, Virginia, United States of America.
  • Lucas A; Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Western Australia, Australia.
  • Moore C; Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, California, United States of America.
  • Sidney J; Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, California, United States of America.
  • Buus S; Laboratory of Experimental Immunology, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Ostrov DA; Department of Pathology, Immunology and Laboratory Medicine, University of Florida College of Medicine, Gainesville, Florida, United States of America.
  • Mallal S; Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Western Australia, Australia; Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
  • Phillips E; Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Western Australia, Australia; Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
  • Shabanowitz J; Department of Chemistry, University of Virginia, Charlottesville, Virginia, United States of America.
  • Hunt DF; Department of Chemistry, University of Virginia, Charlottesville, Virginia, United States of America; Department of Pathology, University of Virginia, Charlottesville, Virginia, United States of America.
  • Preissner R; Charite-University Medicine Berlin, Institute of Physiology & Experimental Clinical Research Center, Berlin, Germany; Graduate School of Computational Systems Biology, Humboldt-Universität zu Berlin, Berlin, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Peters B; Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, California, United States of America.
PLoS One ; 10(5): e0124878, 2015.
Article en En | MEDLINE | ID: mdl-26024233
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antivirales / Aciclovir / Antígenos HLA-B / Hipersensibilidad a las Drogas Límite: Humans Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antivirales / Aciclovir / Antígenos HLA-B / Hipersensibilidad a las Drogas Límite: Humans Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos